KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Return on Invested Capital (2021 - 2023)

Historic Return on Invested Capital for Cardlytics (CDLX) over the last 3 years, with Q1 2023 value amounting to 2.16%.

  • Cardlytics' Return on Invested Capital fell 20900.0% to 2.16% in Q1 2023 from the same period last year, while for Mar 2023 it was 2.16%, marking a year-over-year decrease of 20900.0%. This contributed to the annual value of 0.84% for FY2022, which is 6500.0% down from last year.
  • Latest data reveals that Cardlytics reported Return on Invested Capital of 2.16% as of Q1 2023, which was down 20900.0% from 1.15% recorded in Q4 2022.
  • Over the past 5 years, Cardlytics' Return on Invested Capital peaked at 0.07% during Q1 2022, and registered a low of 2.16% during Q1 2023.
  • In the last 3 years, Cardlytics' Return on Invested Capital had a median value of 0.18% in 2022 and averaged 0.65%.
  • Per our database at Business Quant, Cardlytics' Return on Invested Capital plummeted by -10000bps in 2022 and then plummeted by -20900bps in 2023.
  • Over the past 3 years, Cardlytics' Return on Invested Capital (Quarter) stood at 0.15% in 2021, then tumbled by -680bps to 1.15% in 2022, then crashed by -88bps to 2.16% in 2023.
  • Its last three reported values are 2.16% in Q1 2023, 1.15% for Q4 2022, and 0.15% during Q3 2022.